TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
DBD

Diebold Nixdorf, Incorporated

Technology · Software - Application

63.00$ -2.1% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

Diebold Nixdorf, Incorporated (DBD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 301 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow DBD
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2008 2009 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
94 111 177 189 146 154 164 210 233 117 250 281 281 301 273 215 136 124 187 37 28 37 -104 136 18 123 -388 -257 149 301
33 29 26 35 36 45 61 64 75 76 70 80 80 78 79 80 79 83 74 -64 135 252 259 226 180 149 126 136 132 128
12 12 12 13 14 14 15 22 12 22 34 37 24 15 14 13 13 9.7 12
-54 -58 24 -7.6 -82 2.2 -56 -27 -63 -57 88 76 76 96 70 -28 -53 78 -15 -83 152 -63 -56 116 -1.7 29 -170 -183 39 66
34 68 31 199 43 69 50 73 61 63 44 58 58 44 51 55 50 35 61 59 68 103 59 43 45 51 53 25 17 37
-53 -103 -97 -282 -215 -139 -6.9 -82 -184 -120 -182 -142 -93 -165 -91 -73 -53 14 -65 -561 -121 34 -6.8 -83 -37 -24 -36 -46 -98
31 35 39 42 44 46 48 49 53 58 57 67 67 69 72 73 73 74 75 76 65 31 7.7 0.0 0.0
-8.3 -1.2 -2.3 -13 -1.5 -12 -72 -138 -148 -1.9 -26 -112 -3.5 -4.1 -1.9 -3.0 -2.2 -5.0 -3.0 -1.9 0.0 -131
118 -7.3 376 -300 0.0
-35 -10 -59 78 107 -4.0 -76 -120 -38 27 -24 -84 -84 -133 -111 -124 -36 -204 -81 42 882 -64 11 -216 17 -16 350 560 -367 -144
-35 -10 -59 -15 38 8.6 82 15 14 24 46 35 35 87 0.2 5.3 35 -138 91 -13 339 -110 -85 -178 44 64 -70 273 -281 76
60 44 146 -11 104 86 113 137 171 54 206 223 223 257 222 161 86 89 125 -22 -39 -65 -163 93 -27 72 -441 -282 132 263

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?